Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session III: Current Challenges in Colorectal Cancer
Debate: First-Line Treatment in Left-Sided, RAS/BRAF Wild-Type Metastatic Colorectal Cancer: EGFR Inhibitors vs. VEGF Inhibitors - VEGF INHIBITORS
Wednesday, April 20, 2022
2:53 PM – 3:01 PM
Debate Speaker(s)
Cathy Eng, MD, FACP, FASCO
Vanderbilt-Ingram Cancer Center
MD Anderson Cancer Center